| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination
|
Rahim, Shab E Gul
|
|
|
100 |
1 |
p. 238
|
article
|
| 2 |
Acute kidney injury in pediatric patients hospitalized with acute COVID-19 and multisystem inflammatory syndrome in children associated with COVID-19
|
Basalely, Abby
|
|
|
100 |
1 |
p. 138-145
|
article
|
| 3 |
Acute rejection after anti–SARS-CoV-2 mRNA vaccination in a patient who underwent a kidney transplant
|
Del Bello, Arnaud
|
|
|
100 |
1 |
p. 238-239
|
article
|
| 4 |
Amelioration of chronic kidney disease-associated anemia by vadadustat in mice is not dependent on erythroferrone
|
Hanudel, Mark R.
|
|
|
100 |
1 |
p. 79-89
|
article
|
| 5 |
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
|
Murakami, Naoka
|
|
|
100 |
1 |
p. 196-205
|
article
|
| 6 |
Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy
|
Wu, Liang
|
|
|
100 |
1 |
p. 107-121
|
article
|
| 7 |
APOL1-associated kidney disease in northern Nigerians with treated HIV infection
|
Olabisi, Opeyemi A.
|
|
|
100 |
1 |
p. 19-21
|
article
|
| 8 |
APOL1 genotyping in kidney transplantation: a look into the future
|
Madhavan, Sethu M.
|
|
|
100 |
1 |
p. 32-34
|
article
|
| 9 |
APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra)
|
Kumar, Vineeta
|
|
|
100 |
1 |
p. 30-32
|
article
|
| 10 |
APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro)
|
Freedman, Barry I.
|
|
|
100 |
1 |
p. 27-30
|
article
|
| 11 |
Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria
|
Wudil, Usman J.
|
|
|
100 |
1 |
p. 146-154
|
article
|
| 12 |
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
|
Wheeler, David C.
|
|
|
100 |
1 |
p. 215-224
|
article
|
| 13 |
Calpastatin prevents Angiotensin II–mediated podocyte injury through maintenance of autophagy
|
Bensaada, Imane
|
|
|
100 |
1 |
p. 90-106
|
article
|
| 14 |
Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|
Johansen, Kirsten L.
|
|
|
100 |
1 |
p. 35-48
|
article
|
| 15 |
Corrigendum to Berchtold L, Letouzé E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671–685
|
Berchtold, Lena
|
|
|
100 |
1 |
p. 243
|
article
|
| 16 |
Corrigendum to Tokonami N, Olinger E, Debaix H, Houillier P, Devuyst O. The excretion of uromodulin is modulated by the calcium-sensing receptor. Kidney Int. 2018;94:882–886
|
|
|
|
100 |
1 |
p. 243-244
|
article
|
| 17 |
COVID-19 and the multisystem inflammatory syndrome in children: how vulnerable are the kidneys?
|
Chadha, Vimal
|
|
|
100 |
1 |
p. 16-19
|
article
|
| 18 |
Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19–recovered patients who received a kidney transplant
|
Chang, Chih-Chao
|
|
|
100 |
1 |
p. 240-241
|
article
|
| 19 |
Editorial Board
|
|
|
|
100 |
1 |
p. A1
|
article
|
| 20 |
Epithelial proliferation and cell cycle dysregulation in kidney injury and disease
|
Lee, Kyung
|
|
|
100 |
1 |
p. 67-78
|
article
|
| 21 |
From kidney injury to kidney cancer
|
Peired, Anna Julie
|
|
|
100 |
1 |
p. 55-66
|
article
|
| 22 |
Heavy and light chains all at once: A new immunofluorescence technique to evaluate monoclonal immunoglobulin deposits
|
Santoriello, Dominick
|
|
|
100 |
1 |
p. 22-24
|
article
|
| 23 |
Immunofluorescence staining for immunoglobulin heavy chain/light chain on kidney biopsies is a valuable ancillary technique for the diagnosis of monoclonal gammopathy-associated kidney diseases
|
Nasr, Samih H.
|
|
|
100 |
1 |
p. 155-170
|
article
|
| 24 |
Inhibition of transforming growth factor β1 signaling in resident interstitial cells attenuates profibrotic gene expression and preserves erythropoietin production during experimental kidney fibrosis in mice
|
Fuchs, Michaela A.A.
|
|
|
100 |
1 |
p. 122-137
|
article
|
| 25 |
In this issue
|
|
|
|
100 |
1 |
p. 1
|
article
|
| 26 |
Journal Club
|
|
|
|
100 |
1 |
p. 6-8
|
article
|
| 27 |
Jurisdictional inequalities in deceased donor kidney allocation in Australia
|
Hu, Anne
|
|
|
100 |
1 |
p. 49-54
|
article
|
| 28 |
Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis
|
Caza, Tiffany N.
|
|
|
100 |
1 |
p. 171-181
|
article
|
| 29 |
Novel roles of HIF-PHIs in chronic kidney disease: the link between iron metabolism, kidney function, and FGF23
|
Ikeda, Yasumasa
|
|
|
100 |
1 |
p. 14-16
|
article
|
| 30 |
Oncogenic osteomalacia related to an intramuscular mesenchymal tumor of the scalene muscles
|
Mennetrey, Clément
|
|
|
100 |
1 |
p. 245
|
article
|
| 31 |
Pelvic arteriovenous malformation in a kidney transplant recipient
|
Yamada, Muneharu
|
|
|
100 |
1 |
p. 246
|
article
|
| 32 |
PIEZO2, a mechanosensor in the urinary bladder
|
Gailly, Philippe
|
|
|
100 |
1 |
p. 9-11
|
article
|
| 33 |
Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time
|
Koo, Tai Yeon
|
|
|
100 |
1 |
p. 206-214
|
article
|
| 34 |
Removing race from GFR estimates: balancing potential benefits and unintended consequences
|
Lucas, Anika
|
|
|
100 |
1 |
p. 11-13
|
article
|
| 35 |
Renal amyloidosis with monotypic IgM lambda deposition
|
Manabe, Shun
|
|
|
100 |
1 |
p. 247
|
article
|
| 36 |
SGLT-2 inhibition in IgA nephropathy: the new standard of care?
|
Barratt, Jonathan
|
|
|
100 |
1 |
p. 24-26
|
article
|
| 37 |
Subscription Information
|
|
|
|
100 |
1 |
p. A2
|
article
|
| 38 |
Supplemented ERA-EDTA Registry data evaluated the frequency of dialysis, kidney transplantation, and comprehensive conservative management for patients with kidney failure in Europe
|
Stel, Vianda S.
|
|
|
100 |
1 |
p. 182-195
|
article
|
| 39 |
Table of Contents
|
|
|
|
100 |
1 |
p. A3, A5, A7, A9, A11
|
article
|
| 40 |
The Case | Bilateral submandibular swelling in a dialysis patient
|
Mansour, Farah A.
|
|
|
100 |
1 |
p. 251-252
|
article
|
| 41 |
The Case | Membranous nephropathy after alemtuzumab treatment
|
Rabant, Marion
|
|
|
100 |
1 |
p. 249-250
|
article
|
| 42 |
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment
|
Ariceta, Gema
|
|
|
100 |
1 |
p. 225-237
|
article
|
| 43 |
The PMDA’s view on the limited pipeline of nephrology drugs in Japan
|
Tanaka, Mototsugu
|
|
|
100 |
1 |
p. 241-242
|
article
|
| 44 |
Use of peritoneal dialysis for acute kidney injury during the COVID-19 pandemic in New York City: a multicenter observational study
|
Chen, Wei
|
|
|
100 |
1 |
p. 2-5
|
article
|
Journal description